Fig. 2From: Prognostic impact of immune-related adverse events on patients with and without cardiovascular disease: a retrospective reviewTime to the onset of immune-related adverse events (irAEs) after the first immune checkpoint inhibitor (ICI) administration. The median time from the first ICI administration to the onset of an irAE was 77 (31–168) daysBack to article page